Publication:
The potential prognostic significance of the Laboratory Risk Indicator for the Necrotizing Fasciitis (LRINEC) score in necrotizing fasciitis

dc.contributor.coauthorGönüllü, Doğan
dc.contributor.coauthorİlgün, Ahmet Serkan
dc.contributor.coauthorDemiray, Okan
dc.contributor.coauthorSayar, Samed
dc.contributor.coauthorEr, Ahmet Muzaffer
dc.contributor.coauthorKöksoy, Ferda Nihat
dc.contributor.departmentN/A
dc.contributor.kuauthorKır, Gülay
dc.contributor.schoolcollegeinstituteSchool of Medicine
dc.date.accessioned2024-11-09T12:25:09Z
dc.date.issued2019
dc.description.abstractBackground: we discuss the role of Laboratory Risk Indicator for the Necrotizing Fasciitis (LRINEC) on the prognosis of this disease. Necrotizing Fasciitis (NF) is characterised by rapid spreading of infection and necrosis of the soft tissues and fascia. Methods: thirty patients (17 male, 13 female, mean age 57.5 years) were treated between 2011-2016 (in our center); they were analysed retrospectively regarding age, sex, isolated microbiological agents, modalities of treatment and mortality rate. Results: the majority of the infections were detected in the perineum (14 patients). Other sites of infection were: the presacral region (3 patients), as well as abdominal region after elective (10 patients) and emergency surgery (2 patients), respectively. 53.3% of patients had at least one predisposing comorbid factor such as diabetes mellitus, hypertension, cardiomyopathy and congestive heart failure. The tissue cultures were positive in 12 patients. Mean LRINEC score on admission was 8.5 +/- 2.85. There was a strong correlation between LRINEC score and patient age (p=0.018, R=0.43). LRINEC score was affected by neither gender nor the presence of any comorbidities. The patients were classified according to Wang and Wong staging system, as follows: one patient in stage 1, 15 patients in stage 2 and 14 patients in stage 3. Patients with higher Wang and Wong stages had significantly higher LRINEC scores. The mortality rate was 16.7%. The mean LRINEC score of deceased patients compared to patients who were successfully treated was 9.2 +/- 2.2 and 8.36 +/- 2.9. Conclusion: even though LRINEC score and Wang and Wong stage were significatly related with ICU stay, their direct effect on mortality wasn't significant in our study. / Context: discutăm despre rolul indicatorului de risc de laborator pentru fasceita necrozantă (LRINEC) asupra prognosticului acestei boli. Fasceita necrozantă (NF) se caracterizează prin răspândirea rapidă a infecţiei şi a necrozei ţesutului moale şi a fasciei. Metode: Treizeci de pacienţi (17 bărbaţi, 13 femei, vârsta medie 57,5 ani) au fost trataţi în perioada 2011-2016; au fost analizaţi retrospectiv în ceea ce priveşte vârsta, sexul, agenţii microbiologici izolaţi, modalităţile de tratament şi rata mortalităţii. Rezultate: Majoritatea infecţiilor au fost detectate în perineu (14, 46,7%), alte localizări ale infecţiei fiind regiunea presacrală (3, 10%), regiunea abdominală după intervenţie chirurgicală de elecţie (10,33,3%) şi intervenţie chirurgicală de urgenţă (2, 6.7%). 53,3% dintre pacienţi au prezentat cel puţin un factor comorbid predispozant, cum ar fi diabetul zaharat, hipertensiunea, cardiomiopatia şi insuficienţa cardiacă congestivă. Culturile de ţesut au fost pozitive la 12 (40%) pacienţi. Scorul mediu LRINEC la internare a fost de 8,5 ± 2,85. A existat o corelaţie puternică între scorul LRINEC şi vârsta pacientului (p = 0,018, R = 0,43). Scorul LRINEC nu a fost afectat nici de sex, nici de prezenţa oricăror comorbidităţi. Pacienţii au fost clasificaţi conform sistemului de stadializare Wang şi Wong: 1 pacient în stadiul 1 (3,3%), 15 în stadiul 2 (50%) şi 14 în stadiul 3 (46,7%); pacienţii cu stadii Wang şi Wong mai mari aveau scoruri LRINEC semnificativ mai ridicate. Rata mortalităţii este de 16,7%. Scorul mediu LRINEC al pacienţilor decedaţi a fost de 9,2 ± 2,2 şi al pacienţii în viaţă de 8,36 ± 2,9. Concluzii: Chiar dacă scorul LRINEC şi stadiul Wang şi Wong au fost semnificativ legate de internarea la terapie intensivă, efectul lor direct asupra mortalităţii nu a fost semnificativ în studiul nostru.
dc.description.fulltextYES
dc.description.indexedbyWoS
dc.description.indexedbyScopus
dc.description.issue3
dc.description.openaccessYES
dc.description.publisherscopeInternational
dc.description.sponsoredbyTubitakEuN/A
dc.description.sponsorshipN/A
dc.description.versionPublisher version
dc.description.volume114
dc.formatpdf
dc.identifier.doi10.21614/chirurgia.114.3.376
dc.identifier.embargoNO
dc.identifier.filenameinventorynoIR01789
dc.identifier.issn1221-9118
dc.identifier.linkhttps://doi.org/10.21614/chirurgia.114.3.376
dc.identifier.quartileN/A
dc.identifier.scopus2-s2.0-85069262889
dc.identifier.urihttps://hdl.handle.net/20.500.14288/1547
dc.identifier.wos483362200008
dc.keywordsNecrotizing fasciitis
dc.keywordsLaboratory risk indicator for necrotizing fasciitis
dc.keywordsWang and Wong stages
dc.keywordsTreatment of necrotizing fasciitis
dc.languageEnglish
dc.publisherEditura Celsius
dc.relation.grantnoNA
dc.relation.urihttp://cdm21054.contentdm.oclc.org/cdm/ref/collection/IR/id/8411
dc.sourceChirurgia (Bucharest, Romania: 1990)
dc.subjectSurgery
dc.titleThe potential prognostic significance of the Laboratory Risk Indicator for the Necrotizing Fasciitis (LRINEC) score in necrotizing fasciitis
dc.title.alternativeSemnicatifia potentiala a prognosticului indicatorului de risc de laborator pentru fasceita necrozanta (LRINEC) in cazurile de fascetia necrozanta
dc.typeJournal Article
dspace.entity.typePublication
local.contributor.kuauthorKır, Gülay

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
8411.pdf
Size:
153.87 KB
Format:
Adobe Portable Document Format